Clinical Trial Update: A Multicenter Prospective Study of Iptacopan in the Treatment of Refractory/Relapsed Autoimmune Hemolytic Anemia (AIHA) [NA]

View source ↗

Summary

A multicenter prospective trial evaluating iptacopan for refractory/relapsed autoimmune hemolytic anemia (warm and cold types) is planned but not yet recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Hemolytic Anemia

Drugs mentioned

• iptacopan (iptacopan)

Snippet

Sponsor: Bing Han | Conditions: AIHA - Warm Autoimmune Hemolytic Anemia, AIHA - Cold Autoimmune Hemolytic Anemia | NA | Status: NOT_YET_RECRUITING